Last reviewed · How we verify

BBT-877 single dose

Bridge Biotherapeutics, Inc. · Phase 1 active Small molecule

At a glance

Generic nameBBT-877 single dose
SponsorBridge Biotherapeutics, Inc.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.